When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GILD - Gilead Sciences Wants To Reignite Its NASH Portfolio With 2 Advancements
Gilead Sciences Inc.
Gilead Sciences (GILD) announced two key news items recently. It started off with positive proof of concept NASH results with a double combination treatment, which was presented at the International Liver Congress 2019. Then a few days later, it announced a partnership with Novo Nordisk (NVO) for the development of another NASH combination. While the latest results from the proof of concept are still in the early stages of clinical development, they do offer a lot of promise as the next trials begin.